Array Biopharma (ARRY) Tops Q3 EPS by 38c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.90 -7.49%
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of $0.37, $0.38 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
